ESC Premium Access

Oral donepezil markedly suppresses the progression of cardiovascular remodeling and improves the prognosis in spontaneously hypertensive rats with myocardial infarction

Congress Presentation

About the speaker

Doctor Meihua Li

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
0 follower

8 more presentations in this session

Hemodynamic evaluation of patients with advanced heart failure receiving ambulatory intermittent cycles of levosimendan as bridge to transplant

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Thumbnail

Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support

Speaker: Doctor T. Ichiki (Rochester, US)

Thumbnail

Identification of patients eligible to start sacubitril valsartan in a stable heart failure population

Speaker: Doctor S. Aktaa (Leeds, GB)

Thumbnail

What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

Speaker: Doctor P. Pellicori (Glasgow, GB)

Thumbnail

Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF

Speaker: Doctor M. Senni (Bergamo, IT)

Thumbnail

Access the full session

Poster Session 7 - Chronic heart failure – Treatment

Speakers: Doctor M. Li, Doctor I. Hernandez Gonzalez, Doctor T. Ichiki, Doctor S. Aktaa, Doctor P. Pellicori...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb